Navigation Links
Tennessee Woman’s Biomet Metal Hip Implant Device Failed, Causing Pain, Elevated Metal Ion Levels, and the Need for Revision Surgery, Alleges Lawsuit Filed by Parker Waichman LLP
Date:8/6/2013

New York, New York (PRWEB) August 06, 2013

Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective medical devices, has filed a lawsuit on behalf of a Tennessee woman who alleges that her Biomet M2a Magnum hip implant device is defective and caused her injuries, as well as the need to undergo revision surgery. The suit was filed on May 30, 2013 in the U.S. District Court for the Northern District of Indiana, South Bend Division (Case No. 3:13-cv-508) and is one of many cases pending in the multidistrict litigation (MDL) entitled In re: Biomet M2a Magnum Hip Implants Products Liability Litigation (MDL No. 3:12-md-2391). Biomet, Inc. and Biomet Orthopedics, LLC have been named as Defendants.

According to the Complaint, the Plaintiff was implanted in her left hip with the M2a Magnum system on April 13, 2009. The lawsuit alleges that by the time she underwent this implant surgery, the Defendants were already aware of over 100 adverse event reports linked to the device, yet they failed to disclose this information to the Plaintiff. Instead, the suit alleges, the Defendants misrepresented the M2a Magnum implant as safe and efficacious. Allegedly, the Plaintiff’s surgeon would not have implanted the M2a Magnum had it not been for the misrepresentations made by the Defendants.

The lawsuit alleges that, as a result of the M2a Magnum’s defective design, the Plaintiff’s hip implant failed, causing her severe pain, and resulting in her suffering from elevated metal ion levels. As a result of this, she underwent a complex, risky revision surgery to explant, or remove the device, and be re-implanted with a replacement hip device. The suit alleges that revision surgeries are generally more complex than initial implantation because there is typically less bone to work with when the original device is removed from the body. Revision surgeries usually take longer to complete than the original hip surgery and have a higher rate of complications. The Plaintiff is suing for economic damages, including lost wages, as well as medical and hospital expenses; severe and possibly permanent injuries; pain; suffering; and emotional distress.

The Biomet M2a Magnum is a type of metal-on-metal hip implant. The U.S. Food and Drug Administration (FDA) has put the metal-on-metal class of medical devices under increased scrutiny following reports of high failure rates and the release of elevated concentrations of metallic debris into the bloodstream. On January 17, 2013, the FDA released new guidelines for patients who were implanted with all-metal devices. The agency also advised that regular physical examinations, diagnostic imaging, and metal ion testing be conducted in symptomatic patients.

Additionally, new data from Canada suggests that people implanted with metal-on-metal hips are likelier to have to undergo revision surgery within five years of implantation with the all-metal device, according to a July 18 CBC News report. According to the Canadian Institutes for Health Information study, people who have received metal-on-metal implants face a 5.9 percent increased likelihood of having to undergo device replacement within five years of original implantation; this, in comparison to a 2.7 percent rate among people who received metal-on-plastic implants. The all-metal implant design did not work as expected, CBC News reported. In fact, under the body’s weight during daily activity—such as walking—the implant’s metal parts rub against each other. This rubbing causes metal particles to shed into the person’s surrounding tissue and bloodstream, causing bone and tissue damage due to metallosis (metal poisoning), as well as pseudotumors and the need for early revision surgery to remove and replace the hip with implantation of another device.

Parker Waichman LLP continues to offer free legal consultations to victims of metal-on-metal hip implant injuries. If you or a loved one experienced premature failure of your implant or other health problems associated with a metal-on-metal hip implant, please contact their office by visiting the firm's Defective Hip Implant page at yourlawyer.com. Free case evaluations are also available by calling 1 800 LAW INFO (1-800-529-4636).

Contact:
Parker Waichman LLP
Gary Falkowitz, Managing Attorney
(800) LAW-INFO
(800) 529-4636
http://www.yourlawyer.com

Read the full story at http://www.prweb.com/releases/Biomet_lawsuit_Tennessee/08/prweb11003130.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Basketball Legend Pat Summitt Leaving as Tennessee Womens Coach
2. The Tennessee Car Accident Lawyers at Michael D. Ponce & Associates Alert Public of CDC Survey Revealing Majority of High School Seniors Admitting to Texting Behind Wheel
3. IQware Solutions is Pleased to Announce that IQware MTM has Been Selected by the Tennessee Pharmacists Research and Education Foundation (TPREF)
4. University of Tennessee study: Unexpected microbes fighting harmful greenhouse gas
5. Tennessee Dental Association and Succeed Management Solutions Partner to Deliver New Safety Software Solution for Tennessee Dentists
6. AED.com Donates LifePak CR Plus AED to Tennessee State University Athletic Department
7. University of Tennessee researcher finds first time could predict sexual satisfaction
8. Tennessee Hospitals Take Aim at Medical Error with Aerial Aces
9. Dr. Stephen Lazarus Is a Plastic Surgeon and Expert Injector in Knoxville, Tennessee, Offering New SkinMedica Skin Brightening Product, Lytera
10. Smith & Nephew Hip Recall News: Bernstein Liebhard LLP Notes Motion to Consolidate Smith & Nephew Lawsuits Filed in Tennessee State Courts
11. Middle Tennessee Pest Control Experts U.S. Pest Protection Launch Mobile Website
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their ... Eyeglasses . , Millions of individuals in the United States and Canada wear eyeglasses. ... way to both correct vision and make a fashion statement. Even celebrities use glasses ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... that was developed to enhance the health of felines. The formula is all-natural and ... main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are ...
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... ... ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors in ... School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green Hospital ... at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train in ...
(Date:6/24/2016)... ... , ... A recent article published June 14 on E Online ... on to state that individuals are now more comfortable seeking to undergo not only ... calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 26, 2016 One of Australia,s ... formation of a new biotechnology company, Noxopharm Limited [ABN 50 608 ... IPO and to list on the ASX. Noxopharm is ... to enter a Phase 1 clinical study later this year. ... one of the biggest problems facing cancer patients - the ability ...
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... Antitrust Improvements Act of 1976, as amended ("HSR"), with ... ("Celator"; Nasdaq: CPXX ) expired effective June ... As previously announced on May 31, 2016, Jazz ... under which Jazz Pharmaceuticals has commenced a tender offer ...
(Date:6/26/2016)... June 27, 2016  VMS Rehab Systems, Inc. ( ... take whatever measures required to build a strong and ... is currently listed on the OTC Markets-pink current trading ... and CEO, "We are seeing an anomaly in market ... not only by the Company, but shareholders and market ...
Breaking Medicine Technology: